Ahmed AbdelMoneim Hassan Ali
Quick facts
Phase 3 pipeline
- Rivaroxaban 10 Milligrams · Cardiovascular
Rivaroxaban is a direct Factor Xa inhibitor that blocks the coagulation cascade to prevent blood clot formation.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: